Brown & Brown (BRO)
(Delayed Data from NYSE)
$112.43 USD
+2.08 (1.88%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $112.41 -0.02 (-0.02%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$112.43 USD
+2.08 (1.88%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $112.41 -0.02 (-0.02%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth F Momentum F VGM
Zacks News
Compared to Estimates, Brown & Brown (BRO) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Brown & Brown (BRO) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Brown & Brown's (BRO) Q2 Earnings & Revenues Top Estimates
by Zacks Equity Research
Brown & Brown (BRO) Q2 results reflect improved organic growth and higher net investment income, partly offset by higher expenses.
Brown & Brown (BRO) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Brown & Brown (BRO) delivered earnings and revenue surprises of 15.25% and 6.65%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Marsh & McLennan (MMC) Q2 Earnings Beat on Solid Marsh Business
by Zacks Equity Research
Marsh & McLennan's (MMC) second-quarter results benefit on strong contributions from Risk and Insurance Services as well as Consulting units, partly offset by higher compensation and benefits.
Arthur J. Gallagher (AJG) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Arthur J. Gallagher (AJG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Buy Brown & Brown (BRO) Ahead of Earnings?
by Zacks Equity Research
Brown & Brown (BRO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Brown & Brown (BRO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Brown & Brown (BRO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Arthur J. Gallagher (AJG) Boosts Insurance Business With Buyout
by Zacks Equity Research
Arthur J. Gallagher (AJG) acquires Benchmark to enhance its existing growth opportunities in Southern California.
Marsh & McLennan (MMC) Unit Expands in the Healthcare Industry
by Zacks Equity Research
Marsh & McLennan Companies' (MMC) subsidiary strengthens its position in the healthcare industry through the acquisition of Trideo Systems.
Essent Group (ESNT) Closes Title Insurance Operations Buyout
by Zacks Equity Research
Essent Group (ESNT) concludes the title insurance operations deal, further solidifying its position in the real estate market.
Arthur J. Gallagher (AJG) Up 14% YTD: Will the Bull Run Last?
by Zacks Equity Research
Solid performance of the Brokerage and Risk Management segments, strategic buyouts to capitalize on growing market opportunities and effective capital deployment poise Arthur J. Gallagher (AJG) for growth.
Arthur J. Gallagher (AJG) Expands With Strategic Acquisitions
by Zacks Equity Research
Arthur J. Gallagher's (AJG) buyout of The Andersen Group and Fender Marine AS strengthens its position as a leading global insurance brokerage and risk management firm.
Here's Why Hold Strategy is Apt for Willis Towers (WTW) Stock
by Zacks Equity Research
Willis Towers (WTW) is poised to benefit from growth across global lines of business, strategic inorganic expansion, higher demand for products and advisory work, and a solid balance sheet.
American Financial (AFG) Closes Crop Risk Services Buyout
by Zacks Equity Research
American Financial's (AFG) Great American Insurance Group strengthens its position in the crop insurance market with the acquisition of Crop Risk Services.
Why You Should Consider Buying Brown & Brown (BRO) Stock
by Zacks Equity Research
New businesses, better customer retention, premium-rate increases across the majority of business lines, strategic acquisitions and a strong financial position poise Brown & Brown (BRO) for growth.
Should You Invest in the Invesco S&P 500 Equal Weight Financials ETF (RSPF)?
by Zacks Equity Research
Sector ETF report for RSPF
Is Invesco S&P 500 Equal Weight Financials ETF (RSPF) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RSPF
Marsh & McLennan (MMC) to Help Ukraine With Insurance Access
by Zacks Equity Research
Marsh & McLennan (MMC) collaborates with the Ukrainian government to help it access the commercial insurance market.
eHealth (EHTH) Rallies 90% YTD: Can It Retain the Bull Run?
by Zacks Equity Research
Solid Medicare and Individual, Family and Small Business performance and financial position continue to drive eHealth (EHTH).
Is Brown & Brown (BRO) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Here is how Brown & Brown (BRO) and Banco Santander-Chile (BSAC) have performed compared to their sector so far this year.
Arthur J. Gallagher (AJG) Shares Up 31% YTD: More Upside Left?
by Zacks Equity Research
Solid performance of the Brokerage and Risk Management segments, strategic buyouts to capitalize on growing market opportunities and effective capital deployment continue to drive Arthur J. Gallagher (AJG).
Should You Retain Willis Towers (WTW) Stock in Your Portfolio?
by Zacks Equity Research
Willis Towers (WTW) is poised to benefit from growing healthcare premiums, increased consulting work and software sales, strategic buyouts and effective capital deployment.
Here's Why Investors Should Hold Marsh & McLennan (MMC) Stock
by Zacks Equity Research
Marsh & McLennan (MMC) is currently aided by higher insurance rates, its strong segmental performance and a tactical capital deployment record.
Brown & Brown (BRO) Gains 10% YTD: Will the Rally Continue?
by Zacks Equity Research
New businesses, better customer retention, premium rate increases across the majority of business lines, strategic acquisitions and strong financial position continue to drive Brown & Brown (BRO)
Marsh & McLennan (MMC) Unit Buys SOLV to Better Serve Clients
by Zacks Equity Research
MMA acquires Texas-based SOLV to boost the capabilities and geographic presence of Marsh & McLennan (MMC).